Eligibility is determined after a thorough medical review during your virtual consultation to ensure the program is safe and appropriate for you
When to seek medical advice: Severe pain, swelling, or signs of infection at injection sites Allergic symptoms (rash, difficulty breathing, facial swelling) Unexplained fatigue, jaundice, or dark urine Any concerning symptoms following injection Patients should always disclose use of lipotropic injections to their GP, as this information may be relevant for diagnosis and management of other conditions
You're reacting to your schedule instead of running it
B12 reduces circulating levels of homocysteine, a compound linked to increased risk of heart attack and stroke
If considering the Compounded Tablets tier: ask your assigned provider directly about the bioavailability and absorption pathway for compounded oral GLP-1 peptide medications, and what clinical evidence supports the specific oral formulation being prescribed
The safety profile of usage of glucagon-like peptide-1 receptor agonists in pregnancy: a pharmacovigilance analysis based on the food and drug administration adverse event reporting system